Effect of intravenous heparin on serum levels of endostatin, VEGF and HGF

被引：2

作者：

Bhatia, L ^{[1
]}

Clesham, GJ ^{[1
]}

Turner, DR ^{[1
]}

机构：

[1] Broomfield Hosp, Mid Essex Hosp NHS Trust, Dept Cardiac, Chelmsford CM1 7ET, Essex, England

来源：

CLINICAL SCIENCE | 2004年 / 107卷 / 04期

关键词：

endostatin; heparin; hepatocyte growth factor (HGF); myocardial infarction; vascular endothelial growth factor (VEGF);

D O I：

10.1042/CS20040160

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：423 / 423

页数：1

共 5 条

[1] Serum levels of VEGF and basic FGF in the subacute phase of myocardial infarction [J].

Kawamoto, A ;

Kawata, H ;

Akai, Y ;

Katsuyama, Y ;

Takase, E ;

Sasaki, Y ;

Tsujimura, S ;

Sakaguchi, Y ;

Iwano, M ;

Fujimoto, S ;

Hashimoto, T ;

Dohi, K .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 1998, 67 (01) :47-54

[2] Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin [J].

Sasaki, T ;

Larsson, H ;

Kreuger, J ;

Salmivirta, M ;

Claesson-Welsh, L ;

Lindahl, U ;

Hohenester, E ;

Timpl, R .

EMBO JOURNAL, 1999, 18 (22) :6240-6248

[3] Serum levels of endostatin, vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in patients with acute myocardial infarction undergoing early reperfusion therapy [J].

Seko, Y ;

Fukuda, S ;

Nagai, R .

CLINICAL SCIENCE, 2004, 106 (05) :439-442

[4]

TANIGUCHI T, 1994, LANCET, V344, P470

[5]

TESSLER S, 1994, J BIOL CHEM, V269, P12456

← 1 →